The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.00
Bid: 78.50
Ask: 81.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.822%)
Open: 80.00
High: 80.00
Low: 80.00
Prev. Close: 80.00
BSV Live PriceLast checked at -
British Smaller Companies VCT is an Investment Trust

To maximise Total Return and provide investors with an attractive long-term tax-free dividend yield while maintaining the Company's status as a venture capital trust.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter Results

15 Mar 2024 12:15

RNS Number : 0800H
British Smaller Companies VCT PLC
15 March 2024
 

British Smaller Companies VCT plc

Interim Management Statement

For the quarter ended 31 December 2023

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 31 December 2023. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

In the quarter to 31 December 2023, the Company's Net Asset Value per share was up by 3.3 pence, or 4.0 per cent of the opening NAV, prior to the payment of the interim dividend of 2.0 pence on 8 December 2023. The FTSE Small Cap Index rose by 5.4 per cent during the period.

The Company's Total Return at 31 December 2023 was up 3.3 pence, to 262.6 pence per ordinary share.

During the quarter, the Company invested a further £0.8 million into Force24 and £0.5 million into Vuealta. Subsequent to the quarter end, the Company has invested £1.8 million into three follow on investments; Outpost, Relative Insight and SharpCloud.

In November 2023 the Company exited its investment in E2E for £2.0 million, representing a 2.5x return on the Company's cost. Also in November, the investment in MacroArt was realised for £1.5 million, representing a 2.0x return on cost for the Company. 

The Company has seen further realisations post-quarter-end, partially realising its investments in KeTech and Arcus in January 2024, and fully exiting its investment in Displayplan in February 2024, all at valuations in line with fair value at 31 December 2023.

To maximise shareholder value, the KeTech business was split into its two component parts, Rail and Defence. The Defence business subsequently sold in January 2024, generating proceeds of £1.5 million. To date, the Company has realised proceeds of £4.1 million from its KeTech investment, a 2.0x return on cost, while still retaining its investment in the Rail Business, which at the period end was valued at £1.3 million.

In February 2024, the Company sold its investment in Displayplan for £9.0 million. Total proceeds received over the life of the investment are £12.5 million, an excellent 9.6x return on the Company's cost. There is the potential for further deferred proceeds in due course. 

Performance

The table below sets out movements in key metrics for the Company. 

 

 

30 September 2023

Increase in Value

Shares issued/dividend paid

Buyback of shares

Movement

In Period

31 December 2023

Net Assets (£m)

198.6

7.8

(3.8)

(0.8)

3.2

201.8

NAV per share (PPS)

82.4

3.3

(2.0)

-

1.3

83.7

Cumulative dividends paid (PPS)

176.9

-

2.0

-

2.0

178.9

Total Return (PPS)

259.3

3.3

-

-

3.3

262.6

Shares in issue

240,991,484

-

1,220,008

(975,567)

244,441

241,235,925

Cumulative dividends paid at 31 December 2023 were 178.9 pence per ordinary share (30 September 2023: 176.9 pence per ordinary share) following the interim dividend of 2.0 pence paid on 8 December 2023.

The movements in NAV and NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 30 September 2023

198.6

82.4

Increase in portfolio value

7.6

3.2

Net operating income

0.2

0.1

7.8

3.3

Issue/buy-back of shares

0.2

-

Total Return in the period

8.0

3.3

NAV before dividends

206.6

85.7

Dividends paid

(4.8)

(2.0)

NAV at 31 December 2023

 

201.8

 

83.7

 

Dividends and shares in issue

On 8 December 2023 the Company issued 1,220,008 shares under the Company's Dividend Re-investment Scheme (DRIS).

Under its standing buyback authority, on 18 December 2023 the Company purchased 975,567 shares at 76.88 pence per share at a cost of £0.8 million. These shares are held in treasury. 

On 30 January 2024 the Company issued 22,560,594 shares in relation to its 2023/24 fundraising, following which the Company's issued share capital consists of 263,796,519 ordinary shares with voting rights and 24,501,263 shares held in treasury.

Net assets

Net assets at 31 December 2023 comprised the following:

£000

% of net assets

Unquoted investments at fair value

135,649

67.2

Cash and money market funds

63,490

31.5

Other net assets

2,655

1.3

Net assets

201,794

100.0

Investments

The investment portfolio at 31 December 2023 comprised:

Valuation

£000

Cumulative valuation as a % of net assets

Matillion

26,440

13.1%

Unbiased

12,545

19.3%

Outpost

8,819

23.7%

Displayplan

8,806

28.1%

Elucidat

6,596

31.3%

Force24

6,189

34.4%

Wooshii

5,457

37.1%

SharpCloud

4,965

39.6%

Vypr

4,834

41.9%

ACC Aviation

4,340

44.1%

88,991

44.1%

Other investments

46,658

67.2%

Total investments

135,649

67.2%

Portfolio performance

Over the quarter to 31 December 2023, the aggregate unquoted portfolio valuation has increased by £7.6 million.

Fundraising

The Company announced a new share offer on 20 September 2023, alongside British Smaller Companies VCT2 plc, with the intention of raising up to £90 million, in aggregate, which included an over-allotment facility of £25 million, in aggregate. The offers closed to new Applications on 16 February 2024. Gross Applications of £90 million have been received, of which c.£55.5 million relate to the Company. The first allotment of £30 million (£18.6 million relating to the Company) took place on 30 January 2024; the second and final allotment will take place in early April 2024.

Outlook

In the last quarter of the year, there was a notable upturn in the economic forecast. We witnessed a decline in inflation rates and a growing consensus that interest rates might be lowered in 2024. Nevertheless, we're keeping a close eye on any potential shifts, particularly given recent instability in the Middle East, which have raised concerns about a resurgence in input costs. Additionally, upcoming elections in both the UK and US in 2024 may influence the economic outlook.

The portfolio has demonstrated robust revenue growth in an efficient manner through a tough trading period, which should leave portfolio companies well positioned to continue their positive trajectory as the economic environment improves. Moreover, the close of the Company's 2023/24 fundraising in February positions the Company strongly to continue supporting the portfolio and to invest further in new opportunities in the year ahead.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

15 March 2024

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTEAFDSFSKLEFA
Date   Source Headline
30th May 20147:00 amRNSOffers for Subscription:Allotment of Shares
29th Apr 20147:00 amRNSPostponement of Allotment and Offers Extension
10th Apr 20145:50 pmRNSJoint Offers - Supplementary Propsectus
7th Apr 201410:15 amRNSOffers for Subscription: Allotment of Shares
7th Apr 201410:15 amRNSOffers for Subscription: Allotment of Shares
7th Apr 20147:00 amRNSOffers for Subscription: Allotment of Shares
7th Apr 20147:00 amRNSOffers for Subscription: Allotment of Shares
1st Apr 20145:25 pmRNSOffers for Subscription: Allotment of Shares
27th Mar 20141:15 pmRNSTransaction in Own Shares
24th Feb 201412:35 pmRNSStatement re Adjustment to Offer Price for Shares
18th Feb 20145:30 pmRNSResult of General Meeting
13th Feb 20146:00 pmRNSReduction of Capital
13th Feb 20142:07 pmRNSDividend Declaration
31st Jan 201410:07 amRNSInterim Management Statement & Change of Auditor
15th Jan 20147:30 amRNSPublication of Prospectus re: joint offer
13th Jan 20145:41 pmRNSResult of General Meeting
13th Dec 201311:01 amRNSCircular relating to a General Meeting
28th Nov 20133:51 pmRNSHalf Yearly Report to 30 September 2013
30th Sep 20135:30 pmRNSManagement Arrangements
23rd Sep 20135:17 pmRNSStatement re Proposed Joint Fundraising
12th Sep 20135:56 pmRNSDirector's Purchase of Shares
13th Aug 20134:12 pmRNSIssue of Equity and Dividends Paid
19th Jul 20132:12 pmRNSResult of AGM
19th Jul 20139:14 amRNSInterim Management Statement - June 2013
20th Jun 20135:09 pmRNSCirc re. General Meeting
19th Jun 20134:32 pmRNSTransaction in Own Shares
11th Jun 20134:05 pmRNSAnnual Financial Report to 31 March 2013
15th May 201312:32 pmRNSIssue of Equity
9th May 20132:58 pmRNSIssue of Equity
30th Apr 20134:19 pmRNSIssue of Equity
8th Apr 20138:59 amRNSIssue of Equity
4th Apr 201311:20 amRNSIncrease of Offer Size
28th Mar 20134:13 pmRNSTransaction in Own Shares
23rd Jan 201312:32 pmRNSInterim Management Statement
14th Jan 20132:17 pmRNSIssue of Equity
31st Dec 201212:01 pmRNSAllotment of Shares
18th Dec 20123:30 pmRNSResult of General Meeting
22nd Nov 20127:00 amRNSTransaction in Own Shares
19th Nov 201212:20 pmRNSPublication of Prospectus and Circulars re Offer
13th Nov 20123:22 pmRNSHalf Yearly Report to 30 September 2012
1st Oct 201210:03 amRNSStatement re Proposed Joint Fundraising
17th Aug 20122:51 pmRNSIssue of Equity
13th Aug 20123:41 pmRNSInterim Management Statement to 30 June 2012
20th Jul 20122:22 pmRNSAGM Statement
2nd Jul 201210:59 amRNSTransaction in Own Shares
15th Jun 20127:00 amRNSTransaction in Own Shares
14th Jun 20127:00 amRNSAnnual Financial Report to 31 March 2012
10th Apr 201211:00 amRNSIssue of Equity
21st Mar 20127:00 amRNSIssue of Equity
6th Mar 20123:47 pmRNSDoc re. Top Up Offer for Subscription

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.